These results are also in line with findings in the pre-clinical cell line model, which indicated that reconstitution of wild-type BRCA1 function into human breast cancer HCC1937 cell line caused a 1000-fold increase in sensitivity to taxane and a 20-fold increase in resistance to cisplatin [21]. Here, BRCA1 is linked to breast cancer.